Trials / Unknown
UnknownNCT01226199
The Expression of TLR2 and TLR4 in the Lung of Chronic Obstructive Pulmonary Disease (COPD) Patients
The Expression of TLR2 and TLR4 in the Lung of COPD Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Seoul National University Bundang Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Smoking is the most important risk factor of COPD, but only a fourth of smokers had COPD in their life. There are also healthy smokers without evidence of COPD. Investigators hypothesize that innate immunity may affect this difference between COPD patients and healthy smokers, because TLR4 is the receptor of LPS, which is the one of important substance in cigarette. Investigators will measure TLR2 and TLR4 expression in lung tissue of patients whose lung will be resected. Investigators will compare the level of expression between COPD patients and healthy smokers.
Conditions
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2011-12-01
- Completion
- 2012-03-01
- First posted
- 2010-10-22
- Last updated
- 2011-06-08
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01226199. Inclusion in this directory is not an endorsement.